Genetic Engineering & Biotechnology News (GEN), one of the most widely read biotechnology publications around the globe, profiles INDIGO Biosciences in its October 1, 2010 edition. In an article written by Carol Potera entitled "Screening for Nuclear Receptor Activity," the Company and its focus on Nuclear Receptors are highlighted.

Filling drug pipelines while reducing the risks of toxic or off-target effects of drugs is critical to the pharmaceutical industry. Nuclear Receptors are key targets of drug discovery. INDIGO provides ready to use INDIGO Nuclear Receptor Assay Kits and screening services to the pharmaceutical, biotechnology, food & nutrition, chemical, and agriculture industries.

The GEN profile of INDIGO Biosciences can be found on their website at http://www.genengnews.com/gen-articles/screening-for-nuclear-receptor-ac...